Journey Medical Corporation (DERM) NASDAQ

7.94

-0.19(-2.34%)

Updated at October 29 04:00PM

Currency In USD

Valuation

Market Cap79.89M
Enterprise Value85.29M
P/E Ratio-21.16
PEG Ratio-8.47
Price/Sales Ratio3.43
Price/Book Ratio9.61
Enterprise/Revenue3.52
Enterprise/EBITDA-167.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.15
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.49

Income Statement

Revenue56.13M
Revenue/Share2.42
Gross Profit35.26M
EBITDA-8.4M
Net Income-14.67M
Diluted EPS-0.72

Balance Sheet

Total Cash20.29M
Total Cash/Share0.87
Total Debt25.28M
Total Debt/Equity1.31
Current Ratio1.27
Book Value Per Share0.83

Price History

52-Week Change38.57
52-Week High8.9
52-Week Low3.54
Moving Average 50 Days7.3
Moving Average 200 Days6.58

Statistics

Average Volume154,357
Shares Outstanding24.39M
% Held by Institutions27.66

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A